Resistance of colorectal cancer cells to radiation and 5-FU is associated with MELK expression
- PMID: 21806965
- DOI: 10.1016/j.bbrc.2011.07.060
Resistance of colorectal cancer cells to radiation and 5-FU is associated with MELK expression
Abstract
It was reported that the local recurrence would be caused by cancer stem cells acquiring chemo- and radio-resistance. Recently, one of the potential therapeutic targets for colorectal and other cancers has been identified, which is maternal embryonic leucine zipper kinase (MELK). MELK is known as an embryonic and neural stem cell marker, and associated with the cell survival, cell proliferation, and apoptosis. In this study, SNU-503, which is a rectal cancer cell line, was treated with radiation or 5-fluorouracil (5-FU), and elevation of the MELK expression level was observed. Furthermore, the cell line was pre-treated with small interfering RNA (siRNA) against MELK mRNA before treatment of radiation or 5-FU and its effects on cell cycle and proliferation were observed. We demonstrated that knockdown of MELK reduced the proliferation of cells with radiation or 5-FU treatment. In addition, MELK suppression caused changes in cell cycle. In conclusion, MELK could be associated with increased resistance of colorectal cancer cells against radiation and 5-FU.
Copyright © 2011 Elsevier Inc. All rights reserved.
Similar articles
-
Maternal embryonic leucine zipper kinase (MELK): a novel regulator in cell cycle control, embryonic development, and cancer.Int J Mol Sci. 2013 Oct 31;14(11):21551-60. doi: 10.3390/ijms141121551. Int J Mol Sci. 2013. PMID: 24185907 Free PMC article. Review.
-
Apoptosis, cell cycle progression and gene expression in TP53-depleted HCT116 colon cancer cells in response to short-term 5-fluorouracil treatment.Int J Oncol. 2007 Dec;31(6):1491-500. Int J Oncol. 2007. PMID: 17982676
-
Down-regulation of mitochondrial F1F0-ATP synthase in human colon cancer cells with induced 5-fluorouracil resistance.Cancer Res. 2005 Apr 15;65(8):3162-70. doi: 10.1158/0008-5472.CAN-04-3300. Cancer Res. 2005. PMID: 15833846
-
Involvement of maternal embryonic leucine zipper kinase (MELK) in mammary carcinogenesis through interaction with Bcl-G, a pro-apoptotic member of the Bcl-2 family.Breast Cancer Res. 2007;9(1):R17. doi: 10.1186/bcr1650. Breast Cancer Res. 2007. PMID: 17280616 Free PMC article.
-
Maternal embryonic leucine zipper kinase: key kinase for stem cell phenotype in glioma and other cancers.Mol Cancer Ther. 2014 Jun;13(6):1393-8. doi: 10.1158/1535-7163.MCT-13-0764. Epub 2014 May 2. Mol Cancer Ther. 2014. PMID: 24795222 Free PMC article. Review.
Cited by
-
Maternal embryonic leucine zipper kinase enhances gastric cancer progression via the FAK/Paxillin pathway.Mol Cancer. 2014 May 4;13:100. doi: 10.1186/1476-4598-13-100. Mol Cancer. 2014. PMID: 24885567 Free PMC article.
-
The microRNA expression signature of small cell lung cancer: tumor suppressors of miR-27a-5p and miR-34b-3p and their targeted oncogenes.J Hum Genet. 2017 Jul;62(7):671-678. doi: 10.1038/jhg.2017.27. Epub 2017 Mar 9. J Hum Genet. 2017. PMID: 28275243
-
SATB family chromatin organizers as master regulators of tumor progression.Oncogene. 2019 Mar;38(12):1989-2004. doi: 10.1038/s41388-018-0541-4. Epub 2018 Nov 9. Oncogene. 2019. PMID: 30413763 Review.
-
Maternal embryonic leucine zipper kinase (MELK): a novel regulator in cell cycle control, embryonic development, and cancer.Int J Mol Sci. 2013 Oct 31;14(11):21551-60. doi: 10.3390/ijms141121551. Int J Mol Sci. 2013. PMID: 24185907 Free PMC article. Review.
-
Challenges in validating candidate therapeutic targets in cancer.Elife. 2018 Feb 8;7:e32402. doi: 10.7554/eLife.32402. Elife. 2018. PMID: 29417929 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous
